Evidence

Development of the UrSure test

21-24 JULY 2019

2017

12 AUG 2017 

MAY 2016

The need for objective adherence monitoring

01 Mar 2019

Maximizing the impact of HIV pre-exposure prophylaxis (PrEP) requires optimizing access and adherence for those at risk of contracting HIV.

2018

04-06 JUNE 2017

UrSure tests are accurate

2019

UrSure Assay for TFV to Monitor Adherence in real time to TDF/FTC as PrEP

31 Dec 2016

UrSure tests have clinical impact

01 Mar 2019

01 Oct 2018

Prevention Research

Delivery of TDF/FTC for PrEP to Prevent HIV Using a Urine Adherence Assay

Pre-exposure prophylaxis (PrEP) for HIV prevention with daily tenofovir and emtricitabine is effective when taken consistently. 

2018

2020

2020

2020

Want to stay up to date with UrSure? Join our newsletter!
  • Twitter
  • LinkedIn
EMAIL icon white.png

©  2020 by UrSure, Inc., a wholly-owned subsidiary of OraSure Technologies, Inc., all rights reserved.